Serum hepatocyte growth factor and interleukin-6 as prognostic markers for stage III non-small cell lung cancer.

Hideki Ujiie,Mikio Tomida,Hirohiko Akiyama,Daisuke Okada,Yuki Nakajima,Hiroshi Sakai,Yuichi Takiguchi,Hideki Tanzawa

Serum hepatocyte growth factor and interleukin-6 as prognostic markers for stage III non-small cell lung cancer.

2017

Hideki Ujiie
Mikio Tomida
Hirohiko Akiyama
Daisuke Okada
Yuki Nakajima
Hiroshi Sakai
Yuichi Takiguchi
Hideki Tanzawa

10542 Background: We surveyed prognostic biomarkers for resectable non-small cell lung cancer (NSCLC). Methods: We obtained preoperative serum from 109 patients admitted to our facility, and measur...

Keywords:

Stage III Non-Small Cell Lung Cancer
Internal medicine
Biomarker (medicine)
Hepatocyte growth factor
Oncology
Pathology
non small cell
Interleukin 6
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations